Facebook
X
LinkedIn
ForwardAlcohol Relapse Prevention Strategies Post Liver Transplant
Jefferson, LA US
March 24, 2026
This activity will explore both pharmacologic and non-pharmacologic therapies aimed at preventing alcohol relapse in patients following liver transplantation. Participants will critically evaluate current literature on the use of these therapies in individuals with alcohol use disorder and gain insights into emerging treatment options. Special attention will be given to the clinical application of newer medications and evidence-based approaches to long-term relapse prevention in this unique patient population.
Target Audience
- Pharmacists
- Pharmacy Technicians
- Other Healthcare Professionals
Learning Objectives
At the conclusion of this activity, pharmacists should be able to:
- Describe the significance of relapse risk in liver transplant recipients with alcohol use disorder (AUD).
- Explain the mechanisms of action, dosing strategies, adverse effects, and monitoring requirements for pharmacologic therapies used in the treatment of AUD.
- Critically evaluate current literature regarding the efficacy and safety of pharmacologic treatments for AUD in post–liver transplant patients
At the conclusion of this activity, pharmacy technicians should be able to:
- Identify the importance of assessing relapse risk in patients with alcohol use disorder following liver transplantation.
- Recognize commonly used medications in the treatment of alcohol use disorder, including key administration and safety considerations.
Ochsner Medical Center
1514 Jefferson Hwy.
Jefferson, LA
70121
United States
FACULTY & PLANNERS
Faculty
Haley Brusen, PharmD
PGY2 Solid Organ Transplant Pharmacy Resident
Ochsner Health
PGY2 Solid Organ Transplant Pharmacy Resident
Ochsner Health
Planners
Heather Savage, PharmD, BCPS
Clinical Pharmacist - Internal Medicine
Ochsner Medical Center
Clinical Pharmacist - Internal Medicine
Ochsner Medical Center
Stephanie Anders, PharmD
Clinical Pharmacist - Solid Organ Transplant
Ochsner Medical Center
Clinical Pharmacist - Solid Organ Transplant
Ochsner Medical Center
Samantha Gordon, MS
CE Programs Manager
Vizient, Inc.
Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education
Vizient, Inc.
Director, Continuing Education
Vizient, Inc.
DISCLOSURE
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
Disclosure Statements
Absence of Relevant Financial Relationships
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Statement of Content Validity
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
FDA Off-Label Use
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
Off-label/unapproved drug uses or products are mentioned within this activity.
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Joint PROVIDERSHIP Statement
In support of
improving patient care, this activity has been planned and implemented by Vizient, Inc. and Ochsner Medical Center. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Designation Statement(s)
Pharmacists (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.0 contact hours for Pharmacists.
Universal Activity Number: JA0006103-9999-26-006-L01-P
Pharmacy Technicians (CPE)
Vizient, Inc. designates this live activity for a maximum of 1.0 contact hours for pharmacy technicians.
Universal Activity Number: JA0006103-9999-26-006-L01-T
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
Available Credit
- 1.00 ACPE Pharmacist
- 1.00 ACPE Pharmacy Technician
- 1.00 General CE - Attendance
Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.
Please Note:
- If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
- This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
Please click here to enter the code you received at the end of the activity to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code
Required Hardware/software
The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.